2016 will see the start of safety and tolerability testing of combination anti-retroviral therapy in a phase 2 clinical trial called The Lighthouse Project. The overall aim of the project is to test the possibility that a virus may be a cause or trigger for motor neuron disease (MND).
The study protocol is currently under consideration by the Ethics Committee in Sydney before it can begin. Once approved by regulatory authorities, this trial will be an important step in trying to find the cause of MND and contribute to our scientific understanding of the disease. Information on the trial will be made available on the http://www.clinicaltrials.gov website once it has begun.